These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8473358)

  • 1. Effect of oral activated charcoal on propranolol pharmacokinetics following intravenous administration to rabbits.
    al-Meshal MA; el-Sayed YM; al-Angary AA; al-Dardiri MM
    J Clin Pharm Ther; 1993 Feb; 18(1):39-44. PubMed ID: 8473358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of morphine clearance following intravenous administration by oral activated charcoal in rabbits.
    el-Sayed YM; Hasan MM
    J Pharm Pharmacol; 1990 Aug; 42(8):538-41. PubMed ID: 1981579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of oral activated charcoal on the pharmacokinetics of quinidine and quinine administered intravenously to rabbits.
    Hasan MM; Hassan MA; Rawashdeh NM
    Pharmacol Toxicol; 1990 Jul; 67(1):73-6. PubMed ID: 2395819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated clearance of intravenously administered theophylline and phenobarbital by oral doses of activated charcoal in rats. A possibility of the intestinal dialysis.
    Arimori K; Nakano M
    J Pharmacobiodyn; 1986 May; 9(5):437-41. PubMed ID: 3761133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of selected general anesthetics on pharmacokinetic parameters of some antiarrhythmic drugs in rabbits. Part III. Propranolol.
    Orszulak-Michalak D
    Acta Pol Pharm; 1995; 52(4):309-13. PubMed ID: 8960259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effect of oral activated charcoal on imipramine clearance.
    Goldberg MJ; Park GD; Spector R; Fischer LJ; Feldman RD
    Clin Pharmacol Ther; 1985 Sep; 38(3):350-3. PubMed ID: 4028632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of D-propranolol following oral, intra-arterial and intraportal administration: contrasting effects of oral glucose pretreatment.
    Chow HH; Lalka D
    Biopharm Drug Dispos; 1993 Apr; 14(3):217-31. PubMed ID: 8490110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of charcoal and sorbitol-charcoal suspension on the elimination of intravenous phenobarbital.
    Berg MJ; Rose JQ; Wurster DE; Rahman S; Fincham RW; Schottelius DD
    Ther Drug Monit; 1987; 9(1):41-7. PubMed ID: 3554627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vivo evaluation of propranolol hydrochloride after oral and transdermal administration in rabbits.
    Rao PR; Reddy MN; Ramakrishna S; Diwan PV
    Eur J Pharm Biopharm; 2003 Jul; 56(1):81-5. PubMed ID: 12837485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of oral activated charcoal on the systemic clearance of gentamicin in rabbits with acute renal failure.
    Hasan MM; el-Sayed YM; Abdelaziz AA
    J Pharm Pharmacol; 1990 Feb; 42(2):85-8. PubMed ID: 1972407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal dialysis of digoxin using cholestyramine.
    Rawashdeh NM; al-Hadidi HF; Irshaid YM; Battah AK
    Pharmacol Toxicol; 1993; 72(4-5):245-8. PubMed ID: 8372041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of food on the intravenous and oral dose kinetics of propranolol in the dog.
    Bai SA; Walle UK; Walle T
    J Pharmacokinet Biopharm; 1985 Jun; 13(3):229-41. PubMed ID: 4087163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of activated charcoal on phenytoin pharmacokinetics.
    Rowden AM; Spoor JE; Bertino JS
    Ann Emerg Med; 1990 Oct; 19(10):1144-7. PubMed ID: 2221521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of activated charcoal on the pharmacokinetics of moxifloxacin following intravenous and oral administration of a 400 mg single dose to healthy males.
    Stass H; Kubitza D; Möller JG; Delesen H
    Br J Clin Pharmacol; 2005 May; 59(5):536-41. PubMed ID: 15842551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of oral activated charcoal to accelerate the elimination of amiodarone and chloroquine.
    Laine K; Kivistö KT; Neuvonen PJ
    Hum Exp Toxicol; 1992 Nov; 11(6):491-4. PubMed ID: 1361138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative pharmacokinetics of intravenous propranolol in obese and normal volunteers.
    Cheymol G; Poirier JM; Barre J; Pradalier A; Dry J
    J Clin Pharmacol; 1987 Nov; 27(11):874-9. PubMed ID: 3429695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma concentrations of intravenous beta-methyl digoxin with and without oral charcoal.
    Belz GG
    Klin Wochenschr; 1974 Aug; 52(15):749-50. PubMed ID: 4415089
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative bioavailability of propranolol following oral, intravenous and transdermal administration in rabbits.
    Krishna R; Pandit JK
    Biopharm Drug Dispos; 1993 Dec; 14(9):785-8. PubMed ID: 8298072
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of oral charcoal and urine pH on sotalol pharmacokinetics.
    Kärkkäinen S; Neuvonen PJ
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):441-6. PubMed ID: 6092287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability of propranolol in the dog.
    Tse FL; Sanders TM; Reo JP
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):180-9. PubMed ID: 7224706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.